BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30897853)

  • 21. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
    Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
    Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.
    Katsyv I; Wang M; Song WM; Zhou X; Zhao Y; Park S; Zhu J; Zhang B; Irie HY
    Oncotarget; 2016 Oct; 7(43):69592-69605. PubMed ID: 27612429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
    Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
    J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
    Castillo-Castrejon M; Sankofi BM; Murguia SJ; Udeme AA; Cen HH; Xia YH; Thomas NS; Berry WL; Jones KL; Richard VR; Zahedi RP; Borchers CH; Johnson JD; Wellberg EA
    Breast Cancer Res; 2023 Aug; 25(1):99. PubMed ID: 37608351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor.
    Lin KH; Wang WJ; Wu YH; Cheng SY
    Endocrinology; 2002 Feb; 143(2):467-75. PubMed ID: 11796500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
    Yao-Borengasser A; Monzavi-Karbassi B; Hedges RA; Rogers LJ; Kadlubar SA; Kieber-Emmons T
    Oncol Rep; 2015 Jun; 33(6):2689-94. PubMed ID: 25823469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.
    Lillo MA; Nichols C; Perry C; Runke S; Krutilina R; Seagroves TN; Miranda-Carboni GA; Krum SA
    J Appl Toxicol; 2017 Apr; 37(4):417-425. PubMed ID: 27581495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
    J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.
    Hayashi S; Yamaguchi Y
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):201-6. PubMed ID: 18424035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
    Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
    J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors.
    Zhao Y; Laws MJ; Guillen VS; Ziegler Y; Min J; Sharma A; Kim SH; Chu D; Park BH; Oesterreich S; Mao C; Shapiro DJ; Nettles KW; Katzenellenbogen JA; Katzenellenbogen BS
    Cancer Res; 2017 Oct; 77(20):5602-5613. PubMed ID: 28904064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
    Schwarz LJ; Fox EM; Balko JM; Garrett JT; Kuba MG; Estrada MV; González-Angulo AM; Mills GB; Red-Brewer M; Mayer IA; Abramson V; Rizzo M; Kelley MC; Meszoely IM; Arteaga CL
    J Clin Invest; 2014 Dec; 124(12):5490-502. PubMed ID: 25401474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
    Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
    Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
    Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity inhibits the osteogenic differentiation of human adipose-derived stem cells.
    Strong AL; Hunter RS; Jones RB; Bowles AC; Dutreil MF; Gaupp D; Hayes DJ; Gimble JM; Levi B; McNulty MA; Bunnell BA
    J Transl Med; 2016 Jan; 14():27. PubMed ID: 26818763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma.
    Nahmias Blank D; Hermano E; Sonnenblick A; Maimon O; Rubinstein AM; Drai E; Maly B; Vlodavsky I; Popovtzer A; Peretz T; Meirovitz A; Elkin M
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.